What to Expect From Bed Bath & Beyond Earnings

Photo of Chris Lange
By Chris Lange Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
What to Expect From Bed Bath & Beyond Earnings

© Thinkstock

Bed Bath & Beyond Inc. (NASDAQ: BBBY) is scheduled to report its fiscal second-quarter financial results after the markets close on Wednesday. The consensus estimates from Thomson Reuters call for $1.16 in earnings per share (EPS) on $3.05 billion in revenue. The same period of last year reportedly had $1.21 in EPS on $3.00 billion in revenue.

This company has been a very strong growth story for years, but that was before the recent spate of problems that have plagued Bed Bath & Beyond since early 2015. These problems included meeting earnings estimates or keeping guidance up.

The company has turned to stock buybacks to boost earnings and shrink its float, but it gets to keep buying back stock at lower and lower share prices due to those disappointing headwinds. Even now shares are hovering near 52-week lows.

During the first quarter of fiscal 2016, the company repurchased roughly $178 million of its common stock, representing about 3.8 million shares, under its existing $2.5 billion share repurchase authorization. At the end of May, the program had a remaining balance of $2.1 billion, and it is expected to be completed in fiscal 2019 or fiscal 2020.

[nativounit]

Prior to the release of the earnings report, a few analysts weighed in on Bed Bath & Beyond:

  • Robert Baird has a Hold rating with a $45 price target.
  • Credit Suisse has a Hold rating with a $41 price target.
  • Wedbush reiterated a Neutral rating with a $42 price target.

So far in 2016, Bed Bath & Beyond has underperformed the broad markets, with the stock down 10%. Over the past 52 weeks, the stock is actually down 28%.

Shares of Bed Bath & Beyond were trading at $42.96 on Wednesday, with a consensus analyst price target of $43.06 and a 52-week trading range of $41.15 to $61.90.

[wallst_email_signup]

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618